BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Bonito P, Accardi L, Galati L, Ferrantelli F, Federico M. Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes. Cancers (Basel) 2019;11:E138. [PMID: 30682811 DOI: 10.3390/cancers11020138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu Q, Chen Y, Jin Y, Wang Z, Dong H, Kaufmann AM, Albers AE, Qian X. Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer. Viruses 2022;14. [PMID: 36560828 DOI: 10.3390/v14122824] [Reference Citation Analysis]
2 Negahdaripour M, Vakili B, Nezafat N. Exosome-based vaccines and their position in next generation vaccines. International Immunopharmacology 2022;113:109265. [DOI: 10.1016/j.intimp.2022.109265] [Reference Citation Analysis]
3 Liu Q, Guo Z, Wang E, Wang G, Liu T. Immunopotentiation mechanism of a mannose-modified peptide fragment containing a dominant antigenic epitope of Micropterus salmoides rhabdovirus (MSRV) glycoprotein after coupling to nanocarrier. Aquaculture 2022;561:738625. [DOI: 10.1016/j.aquaculture.2022.738625] [Reference Citation Analysis]
4 Liu G, Wu J, Chen G, Shang A. The potential therapeutic value and application prospect of engineered exosomes in human diseases. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1051380] [Reference Citation Analysis]
5 Jangholi A, Müller Bark J, Kenny L, Vasani S, Rao S, Dolcetti R, Punyadeera C. Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma. Biochim Biophys Acta Rev Cancer 2022;1877:188784. [PMID: 36028150 DOI: 10.1016/j.bbcan.2022.188784] [Reference Citation Analysis]
6 Stoyanova E, Mihaylova N, Ralchev N, Ganova P, Bradyanova S, Manoylov I, Raynova Y, Idakieva K, Tchorbanov A. Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma. Mar Drugs 2022;20:392. [PMID: 35736195 DOI: 10.3390/md20060392] [Reference Citation Analysis]
7 Hu X, Zhou W, Pi R, Zhao X, Wang W. Genetically modified cancer vaccines: Current status and future prospects. Med Res Rev 2022. [PMID: 35235212 DOI: 10.1002/med.21882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Huda MN, Nurunnabi M. Potential Application of Exosomes in Vaccine Development and Delivery. Pharm Res 2022. [PMID: 35028802 DOI: 10.1007/s11095-021-03143-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Mirzaei H, Rahimian N, Mirzaei HR, Nahand JS, Hamblin MR. Role of Exosomes in the Treatment of Diseases. Exosomes and MicroRNAs in Biomedical Science 2022. [DOI: 10.1007/978-3-031-79177-2_8] [Reference Citation Analysis]
10 Teng Y, Gao L, Loveless R, Rodrigo JP, Strojan P, Willems SM, Nathan CA, Mäkitie AA, Saba NF, Ferlito A. The Hidden Link of Exosomes to Head and Neck Cancer. Cancers (Basel) 2021;13:5802. [PMID: 34830956 DOI: 10.3390/cancers13225802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sun Z, Zhang J, Li J, Li M, Ge J, Wu P, You B, Qian H. Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy. Stem Cells Int 2021;2021:9962194. [PMID: 34335792 DOI: 10.1155/2021/9962194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T, Nurunnabi M. Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications. ACS Biomater Sci Eng 2021;7:2106-49. [PMID: 33988964 DOI: 10.1021/acsbiomaterials.1c00217] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
13 Chen L, Li Z, Zeng T, Zhang YH, Liu D, Li H, Huang T, Cai YD. Identifying Robust Microbiota Signatures and Interpretable Rules to Distinguish Cancer Subtypes. Front Mol Biosci 2020;7:604794. [PMID: 33330634 DOI: 10.3389/fmolb.2020.604794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
14 Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C. Therapeutic Vaccines for HPV-Associated Malignancies. Immunotargets Ther 2020;9:167-200. [PMID: 33117742 DOI: 10.2147/ITT.S273327] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
15 Kumar A, Kodidela S, Tadrous E, Cory TJ, Walker CM, Smith AM, Mukherjee A, Kumar S. Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention. Viruses 2020;12:E887. [PMID: 32823684 DOI: 10.3390/v12080887] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
16 Hofmann L, Ludwig S, Vahl JM, Brunner C, Hoffmann TK, Theodoraki MN. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer. Int J Mol Sci 2020;21:E4072. [PMID: 32517240 DOI: 10.3390/ijms21114072] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
17 Stoyanova E, Mihaylova N, Manoylov I, Bradyanova S, Raynova Y, Idakieva K, Tchorbanov A. Intensive therapy with gastropodan hemocyanins increases their antitumor properties in murine model of colon carcinoma. Int Immunopharmacol 2020;84:106566. [PMID: 32416451 DOI: 10.1016/j.intimp.2020.106566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Chiantore MV, Mangino G, Iuliano M, Capriotti L, Di Bonito P, Fiorucci G, Romeo G. Human Papillomavirus and carcinogenesis: Novel mechanisms of cell communication involving extracellular vesicles. Cytokine Growth Factor Rev 2020;51:92-8. [PMID: 31973992 DOI: 10.1016/j.cytogfr.2019.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Xiao C, Song F, Zheng YL, Lv J, Wang QF, Xu N. Exosomes in Head and Neck Squamous Cell Carcinoma. Front Oncol 2019;9:894. [PMID: 31620359 DOI: 10.3389/fonc.2019.00894] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
20 Apostolopoulos V. Cancer Vaccines: Research and Applications. Cancers (Basel) 2019;11:E1041. [PMID: 31344788 DOI: 10.3390/cancers11081041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
21 Zhou Y, Höti N, Ao M, Zhang Z, Zhu H, Li L, Askin F, Gabrielson E, Zhang H, Li QK. Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact. Biomark Med 2019;13:761-71. [PMID: 31157548 DOI: 10.2217/bmm-2018-0441] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
22 Nimrichter L, Rodrigues ML, Del Poeta M. Exploiting Lipids to Develop Anticryptococcal Vaccines. Curr Trop Med Rep 2019;6:55-63. [DOI: 10.1007/s40475-019-00178-x] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]